These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 32909117)

  • 1. AKT/GSK-3β/β-catenin signaling pathway participates in erythropoietin-promoted glioma proliferation.
    Tang Z; Yang G; Wang X; Chen F; Liao Z; Zhang Z; Liu Z; Zeng W; Fang M; Wang W; Sun X; Huo G
    J Neurooncol; 2020 Sep; 149(2):231-242. PubMed ID: 32909117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FAM84B acts as a tumor promoter in human glioma via affecting the Akt/GSK-3β/β-catenin pathway.
    Wang M; Li C; Shi W
    Biofactors; 2021 Jul; 47(4):600-611. PubMed ID: 33759248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular 5'-nucleotidase (CD73) promotes human breast cancer cells growth through AKT/GSK-3β/β-catenin/cyclinD1 signaling pathway.
    Yu J; Wang X; Lu Q; Wang J; Li L; Liao X; Zhu W; Lv L; Zhi X; Yu J; Jin Y; Zou Q; Ou Z; Liu X; Zhou P
    Int J Cancer; 2018 Mar; 142(5):959-967. PubMed ID: 29047106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lnc GNG12-AS1 knockdown suppresses glioma progression through the AKT/GSK-3β/β-catenin pathway.
    Xiang Z; Lv Q; Chen X; Zhu X; Liu S; Li D; Peng X
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32735016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA OIP5-AS1 targets Wnt-7b to affect glioma progression via modulation of miR-410.
    Sun WL; Kang T; Wang YY; Sun JP; Li C; Liu HJ; Yang Y; Jiao BH
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30498093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical exercise suppresses hepatocellular carcinoma progression by alleviating hypoxia and attenuating cancer stemness through the Akt/GSK-3β/β-catenin pathway.
    Xiao CL; Zhong ZP; Lü C; Guo BJ; Chen JJ; Zhao T; Yin ZF; Li B
    J Integr Med; 2023 Mar; 21(2):184-193. PubMed ID: 36781361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oroxylin A reversed Fibronectin-induced glioma insensitivity to Temozolomide by suppressing IP
    Ding Y; Zhou Y; Li Z; Zhang H; Yang Y; Qin H; Xu Q; Zhao L
    Life Sci; 2020 Nov; 260():118411. PubMed ID: 32918978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NCSTN promotes hepatocellular carcinoma cell growth and metastasis via β-catenin activation in a Notch1/AKT dependent manner.
    Li H; Lan T; Xu L; Liu H; Wang J; Li J; Chen X; Huang J; Li X; Yuan K; Zeng Y; Wu H
    J Exp Clin Cancer Res; 2020 Jul; 39(1):128. PubMed ID: 32631394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of lnc-ZNF281 Inhibits the Progression of Glioma via the AKT/GSK-3
    Deng YQ; Kong GY; Li S; Li F; Wen SL
    J Immunol Res; 2021; 2021():5573071. PubMed ID: 34056009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Erythropoietin accelerates the proliferation of glioma cells via activating Akt pathway].
    Liu ZL; Tang ZH; Huo G; Chen FL; Wang WT; Zeng WX; Chen H; Li X; Chen C
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Apr; 38(4):395-401. PubMed ID: 29735438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZNF326 promotes malignant phenotype of glioma by up-regulating HDAC7 expression and activating Wnt pathway.
    Yu X; Wang M; Wu J; Han Q; Zhang X
    J Exp Clin Cancer Res; 2019 Jan; 38(1):40. PubMed ID: 30691485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of DDX46 suppresses the proliferation and invasion of gastric cancer through inactivating Akt/GSK-3β/β-catenin pathway.
    Chen L; Xu M; Zhong W; Hu Y; Wang G
    Exp Cell Res; 2021 Feb; 399(1):112448. PubMed ID: 33347858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. POTEE stimulates the proliferation of pancreatic cancer by activating the PI3K/Akt/GSK-3β/β-catenin signaling.
    Hao Q; Gao L; Niu W; Chen L; Zhang P; Chen Z
    Biofactors; 2020 Jul; 46(4):685-692. PubMed ID: 32589786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GSK-3β regulates tumor growth and angiogenesis in human glioma cells.
    Zhao P; Li Q; Shi Z; Li C; Wang L; Liu X; Jiang C; Qian X; You Y; Liu N; Liu LZ; Ding L; Jiang BH
    Oncotarget; 2015 Oct; 6(31):31901-15. PubMed ID: 26388612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AQP8 may affect glioma proliferation and growth by regulating GSK-3β phosphorylation and nuclear transport of β-catenin.
    Cai Z; Shen Z; Zhao J; Zhang H; Guo Z; Xia Q; Liang H; Liu J; Tan L; Sheng H; Zhu S
    Int J Dev Neurosci; 2023 Jun; 83(4):333-345. PubMed ID: 37081713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis.
    Xu X; Zou L; Yao Q; Zhang Y; Gan L; Tang L
    Oncol Rep; 2017 Aug; 38(2):1035-1042. PubMed ID: 28627610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Par6 regulates cell cycle progression through enhancement of Akt/PI3K/GSK-3β signaling pathway activation in glioma.
    Liu P; Zhu C; Luo J; Lan S; Su D; Wang Q; Wei Z; Cui W; Xu C; Yang X
    FASEB J; 2020 Jan; 34(1):1481-1496. PubMed ID: 31914615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vimentin loss promotes cancer proliferation through up-regulating Rictor/AKT/β-catenin signaling pathway.
    Ding Y; Lv C; Zhou Y; Zhang H; Zhao L; Xu Y; Fan X
    Exp Cell Res; 2021 Aug; 405(1):112666. PubMed ID: 34052237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erinacine Facilitates the Opening of the Mitochondrial Permeability Transition Pore Through the Inhibition of the PI3K/ Akt/GSK-3β Signaling Pathway in Human Hepatocellular Carcinoma.
    Zhou LJ; Mo YB; Bu X; Wang JJ; Bai J; Zhang JW; Cheng AB; Ma JH; Wang YW; Xie YX
    Cell Physiol Biochem; 2018; 50(3):851-867. PubMed ID: 30355923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
    Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y
    Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.